Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-α inhibitors
{{output}}
The use of tumor necrosis factor-α (TNF-α) inhibitors has been increasing especially in patients with rheumatoid arthritis (RA). As TNF-α inhibitors are strongly immunosuppressive, the occurrence of hepatitis B virus (HBV) reactivation has recently been obs... ...
